← All Virpax Pharmaceuticals, INC filings

Virpax Pharmaceuticals, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
VRPX
Virpax Pharmaceuticals, INC
10-K: Virpax Pharmaceuticals Reports Fiscal Year 2024 Results, Navigates Financial Challenges
Virpax Pharmaceuticals details its financial results for 2024, highlighting ongoing losses, efforts to secure additional funding, and strategic shifts in corporate governance and product development.
OTC.Pink
VRPX
Virpax Pharmaceuticals, INC
10-K/A: Virpax Pharmaceuticals Files Amended 10-K, Includes Auditor's Report and Details Ongoing Development
Virpax Pharmaceuticals files an amendment to its annual report to include the auditor's report and provides updates on its pipeline and financial status.
OTC.Pink
VRPX
Virpax Pharmaceuticals, INC
10-K/A: Virpax Pharmaceuticals Files Amended 10-K to Include Auditor's Report
Virpax Pharmaceuticals files an amendment to its 2022 annual report to include the independent auditor's report, with no other material changes to the original filing.
OTC.Pink
VRPX
Virpax Pharmaceuticals, INC
10-K: Virpax Pharmaceuticals Details Share Structure and Regulatory Framework in 10-K Filing
Virpax Pharmaceuticals outlines its capital structure, stock details, and regulatory compliance in its annual 10-K filing.